Heyuan biological purchase date

Heyuan Bio bought it online on March 1 1, with the purchase code of 787238, and the announcement date of the winning number was March 15. Unit profile: Heyuan Bio, located in Shanghai, was founded on 20 13. Haitong Securities Co., Ltd. subscribed on Friday, March 20221/kloc-0. The issue price-earnings ratio is 244.67 times, and the industry price-earnings ratio is 765,438+0.72 times. Main business, focusing on basic research of gene therapy, providing CRO services such as gene therapy carrier development and gene function research, and providing CDMO services such as IND-CMC pharmaceutical research and clinical sample GMP production for gene drug research and development. Upstream of the industrial chain, suppliers of equipment, instruments, reagents and consumables. Downstream of industrial chain, gene therapy new drug research and development company. Well-known customers: Shenzhen Yinuowei Pharmaceutical Technology Co., Ltd., First Affiliated Hospital of Army Military Medical University, Cancer Hospital of Sun Yat-sen University, First Affiliated Hospital of China Medical University. Customer concentration, during the reporting period, the total sales amount of the top five customers of the company accounted for 33.40% and 36.97% of the main business income of the single machine respectively. 565,438+0.23% and 565,438+0.85%, and the overall customer concentration is on the rise.